Physician profile
Sylvia Suarez
NPI 1275642787
$8,029.31
in general payments reported to CMS, 2019-2025
35 companies · $1,502 in 2025
The $1,502 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,827 · 2020: $1,018 · 2021: $353 · 2022: $881 · 2023: $1,128 · 2024: $1,319 · 2025: $1,502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,921 · Education: $28.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,920.91 |
| Education | $28.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $952.79 | 2019-2025 | Tremfya, Simponi Aria, Simponi |
| Abbvie INC. | $789.04 | 2019-2025 | Rinvoq, Skyrizi |
| Sun Pharmaceutical Industries INC. | $531.60 | 2020-2025 | Winlevi, Absorica Ld |
| E.R. Squibb & Sons, L.L.C. | $493.60 | 2023-2025 | Sotyktu |
| Incyte Corporation | $448.77 | 2021-2025 | Opzelura |
| Mayne Pharma Commercial LLC | $424.53 | 2019-2022 | |
| Galderma Laboratories, L.P. | $396.42 | 2019-2025 | Nemluvio, Aklief, Oracea |
| Ucb, INC. | $385.79 | 2019-2025 | Bimzelx |
| Pfizer INC. | $365.14 | 2019-2024 | |
| Lilly USA, LLC | $334.51 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| Journey Medical Corporation | $332.40 | 2019 | |
| Arcutis Biotherapeutics, INC. | $278.91 | 2023-2025 | Zoryve |
| Leo Pharma INC. | $258.17 | 2019-2025 | Adbry, Anzupgo |
| Amgen INC. | $257.76 | 2019-2025 | Otezla, Otezla |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $243.77 | 2019-2025 | Jublia, Siliq, Cabtreo |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $205.55 | 2019-2025 | |
| Celgene Corporation | $201.41 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $158.93 | 2019-2024 | Dupixent |
| Encore Dermatology INC. | $140.96 | 2019-2020 | |
| Dermavant Sciences, INC. | $102.52 | 2024 | Vtama |
| Epi Health, LLC | $101.19 | 2019-2022 | |
| Almirall LLC | $94.79 | 2019-2020 | |
| Medimetriks Pharmaceuticals, INC. | $85.35 | 2020-2025 | |
| Genzyme Corporation | $77.16 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $66.86 | 2021 | |
| Sandoz INC. | $64.53 | 2019 | |
| Sebela Pharmaceuticals INC. | $59.77 | 2019-2020 | |
| Dermira, INC. | $37.10 | 2019-2020 | |
| Biofrontera INC. | $25.10 | 2019 | |
| Organon LLC | $24.82 | 2025 | Vtama |
| Vyne Pharmaceuticals INC. | $24.74 | 2020 | |
| Lnhc, INC | $23.02 | 2025 | Zelsuvmi |
| Strata Skin Sciences, INC. | $18.14 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.17 | 2025 | Tremfya |
| Glenmark Therapeutics INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sylvia Suarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.